Cidara Therapeutics Inc (NASDAQ:CDTX)
| 0.7399 Delayed Data As of Dec 08 |  -0.0013 / -0.18%Today’s Change | 0.46 Today|||52-Week Range 2.10 | -2.17% Year-to-Date |
Latest CDTX News | Press Releases
No recent news for Cidara Therapeutics Inc.
Today’s Trading
| Previous close | 0.74 |
| Today’s open | 0.75 |
| Day’s range | 0.73 - 0.75 |
| Volume | 5,135 |
| Average volume (3 months) | 438,905 |
| Market cap | $70.6M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +47.31% |
| Earnings growth (this year) | +46.51% |
| Earnings growth (next 5 years) | +67.40% |
| Revenue growth (last year) | +29.69% |
| P/E ratio | NM |
| Price/Sales | 0.82 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CATXPerspective Therapeu... | -0.00 | -0.98% |
| ---- | ||
| LFVNLifeVantage Corp | +0.24 | +3.61% |
| ---- |
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | February 28, 2024 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $64.3M |
| Annual profit (last year) | -$29.8M |
| Net profit margin | -46.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
